Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Clonal Hematopoiesis Is Associated with Non-Myeloid Subsequent Malignant Neoplasms after Autologous Hematopoietic Cell Transplantation

June-Wha Rhee, Sitong Chen, Raju Pillai, Alysia Bosworth, Artem Oganesyan, Liezl Atencio, Caitlyn Estrada, Mareen Kassabian, Lanie Lindenfeld, Scott R. Goldsmith, Michael Rosenzweig, Alex F. Herrera, Matthew Mei, Ryotaro Nakamura, F. Lennie Wong, Stephen J. Forman, Saro Armenian

Blood (2024) 144 (Supplement 1): 947.

https://doi.org/10.1182/blood-2024-200402

Published: 2024

Journal Articles

Clonal Hematopoiesis and Venous Thromboembolism Risk in Lymphoma Patients Surviving Autologous Transplantation

Radhika Gangaraju, Yanjun Chen, Lindsey Hageman, Elizabeth Ross, Liton Francisco, David K Crossman, Purnima Singh, Alysia Bosworth, Daniel Weisdorf, Ravi Bhatia, Saro Armenian, Stephen J. Forman, Smita Bhatia

Blood (2024) 144 (Supplement 1): 14.

https://doi.org/10.1182/blood-2024-201067

Published: 2024

Journal Articles

Self-Rated Health Is an Independent Predictor of Subsequent Late Mortality after Blood or Marrow Transplantation (BMT) Among Survivors of Myeloid Malignancies: A BMTSS Report

Nora Balas, Joshua Richman, Wendy Landier, Sadeep Shrestha, Katia J Bruxvoort, Lindsey Hageman, Qingrui Meng, Elizabeth Ross, Alysia Bosworth, Hok Sreng Te, F. Lennie Wong, Ravi Bhatia, Stephen J. Forman, Saro Armenian, Daniel Weisdorf, Smita Bhatia

Blood (2024) 144 (Supplement 1): 403.

https://doi.org/10.1182/blood-2024-204551

Published: 2024

Journal Articles

Social Vulnerability Is an Important Predictor of Cardiovascular Disease Risk after Allogeneic Hematopoietic Cell Transplantation

Osariemen Ogiamien, Sitong Chen, MHD Monzr M. Al Malki, Andrew Artz, Liezl Atencio, Alysia Bosworth, Meagan Echevarria, Caitlyn Estrada, Mareen Kassabian, Lanie Lindenfeld, Ryotaro Nakamura, June-Wha Rhee, F. Lennie Wong, Saro Armenian, Rusha Bhandari

Blood (2024) 144 (Supplement 1): 4924.

https://doi.org/10.1182/blood-2024-203678

Published: 2024

Journal Articles

Individual- and Area-Level Socioeconomic Disadvantage and Risk of Death Due to Chronic Health Conditions Among Autologous Blood or Marrow Transplant (autoBMT) Recipients for Lymphoma: A BMT Survivor Study (BMTSS) Report

Aman Wadhwa, Benjamin Grey Vandeberg, Qingrui Meng, Lindsey Hageman, Alysia Bosworth, Lucia Juarez, Ariann Nassel, Elizabeth Baker, Gabriela Oates, Wendy Landier, Elizabeth Ross, Sarah Palmer, Nora Balas, Liton Francisco, Ravi Bhatia, Daniel Weisdorf, Saro Armenian, Smita Bhatia

Blood (2024) 144 (Supplement 1): 3715.

https://doi.org/10.1182/blood-2024-209190

Published: 2024

Journal Articles

Predictors of Risky Health Behaviors Among Blood or Marrow Transplant (BMT) Survivors of Myeloid Malignancies - a BMT Survivor Study (BMTSS)

Blood (2024) 144 (Supplement 1): 5053.

https://doi.org/10.1182/blood-2024-204662

Published: 2024

Journal Articles

Self-Rated Health Is an Independent Predictor of Late Mortality after Blood or Marrow Transplantation (BMT) Among Survivors of Plasma Cell Disorders: A BMTSS Report

Blood (2024) 144 (Supplement 1): 5146.

https://doi.org/10.1182/blood-2024-204623

Published: 2024

Journal Articles

Predictors of Risky Health Behaviors Among Blood or Marrow Transplant (BMT) Survivors of Lymphoid Malignancies - a BMT Survivor Study (BMTSS)

Blood (2024) 144 (Supplement 1): 5036.

https://doi.org/10.1182/blood-2024-204686

Published: 2024

Journal Articles

Self-Rated Health Is an Independent Predictor of Subsequent Late Mortality after Blood or Marrow Transplantation (BMT) Among Survivors of Lymphoid Malignancies: A BMTSS Report

Blood (2024) 144 (Supplement 1): 2338.

https://doi.org/10.1182/blood-2024-204642

Published: 2024

Journal Articles

Long-Term Health Outcomes in Older (≥60 Years) Blood or Marrow Transplantation (BMT) Recipients: A Report from the Blood or Marrow Transplant Survivor Study (BMTSS)

Rusha Bhandari, Qingrui Meng, Nora Balas, Alysia Bosworth, F. Lennie Wong, Wendy Landier, Liton Francisco, Elizabeth Ross, Ravi Bhatia, Smita Bhatia, Saro Armenian, Lindsey Hageman

Blood (2024) 144 (Supplement 1): 2411.4.

https://doi.org/10.1182/blood-2024-199277

Published: 2024

Journal Articles

Clonal Hematopoiesis Is Associated with Cardiovascular Disease Risk and Worse Survival after Autologous Hematopoietic Cell Transplantation for Lymphoma

Blood (2023) 142 (Supplement 1): 784.

https://doi.org/10.1182/blood-2023-177832

Published: 2023

Journal Articles

Impact of Health Insurance and Access to Autologous Stem Cell Transplantation (ASCT) on Racial Inequity in Overall Survival (OS) Among Patients with Multiple Myeloma (MM)

F. Lennie Wong, Scott R. Goldsmith, Kimlin Ashing, Amrita Krishnan, Michael Rosenzweig, Saro Armenian

Blood (2023) 142 (Supplement 1): 4730.

https://doi.org/10.1182/blood-2023-174296

Published: 2023

Journal Articles

Clonal Hematopoiesis Is Associated with Severe Cytokine Release Syndrome in Patients Treated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy

Scott R. Goldsmith, Geoffrey P. Shouse, F. Lennie Wong, Alysia Bosworth, Aleksi Iujuridze, Sitong Chen, June-Wha Rhee, Matthew G. Mei, Murali Janakiram, Myo Htut, Stephen J. Forman, Raju Pillai, L. Elizabeth Budde, Saro Armenian

Blood (2023) 142 (Supplement 1): 4814.

https://doi.org/10.1182/blood-2023-185157

Published: 2023

Journal Articles

Targeted Immunotherapy and Checkpoint Blockade in Children, Adolescents, and Young Adults with Lymphoma: Radical Hodgkin Cohort

Kayleigh Klose, Jessica Hochberg, Jaclyn Basso, Ana C. Xavier, Matthew J. Barth, Rodney R. Miles, Samir Kahwash, Stephan D. Voss, Suzanne Braniecki, Chitti Moorthy, Saro Armenian, Matthew J. Ehrhardt, Megan Lim, Lauren Harrison, Arvind Budhram, Ariel Stonberg, Stanton Goldman, Mitchell S. Cairo

Blood (2023) 142 (Supplement 1): 3083.

https://doi.org/10.1182/blood-2023-186691

Published: 2023

Journal Articles

Disability Adjusted Life-Years (DALYs) As a Measure of the Changing Lifetime Disease Burden in Long-Term Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT)

Sitong Chen, Alysia Bosworth, Liezl Atencio, MHD Monzr Al Malki, Stephen J. Forman, Ryotaro Nakamura, Saro Armenian, F. Lennie Wong

Blood (2023) 142 (Supplement 1): 238.

https://doi.org/10.1182/blood-2023-174107

Published: 2023

Journal Articles

Pembrolizumab plus vorinostat induces responses in patients with Hodgkin lymphoma refractory to prior PD-1 blockade

Blood (2023) 142 (16): 1359–1370.

https://doi.org/10.1182/blood.2023020485

Published: 2023

Includes: Supplemental data

Journal Articles

Response-adapted anti-PD-1–based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE

Blood (2022) 139 (25): 3605–3616.

https://doi.org/10.1182/blood.2022015423

Published: 2022

Includes: Supplemental data

Journal Articles

Pembrolizumab Plus Vorinostat Induces Responses in Patients with Hodgkin Lymphoma Who Are Refractory to Prior PD-1 Blockade

Alex F. Herrera, Lu Chen, L. Elizabeth Budde, Saro Armenian, Liana Nikolaenko, Robert Chen, Shari Daniels, Neena Kennedy, Lacolle Peters, Steven T. Rosen, Stephen J Forman, Leslie L. Popplewell, Larry W. Kwak, Matthew Mei

Blood (2021) 138 (Supplement 1): 234.

https://doi.org/10.1182/blood-2021-150031

Published: 2021

Journal Articles

Long-Term Follow up of Patients with HIV-Associated Non-Hodgkin Lymphoma (NHL) after Autologous Stem Cell Transplantation (ASCT)

Liana Nikolaenko, MD, Saro Armenian, DO, MPH, Joseph C. Alvarnas, MD, John A. Zaia, MD, Leanne Goldstein, DrPH, Maria Viviana Marroquin, Amrita Y. Krishnan, MD

Blood (2016) 128 (22): 4614.

https://doi.org/10.1182/blood.V128.22.4614.4614

Published: 2016

Journal Articles

Impact of Self-Reported Pre-Transplant Quality of Life (QOL) on Long-Term Survival after Allogeneic or Autologous Hematopoietic Cell Transplantation (HCT)

F. Lennie Wong, PhD, Jennifer Berano-Teh, Liton F. Francisco, BS, Aida Siyahian, Liezl Atencio, Alicia Gonzales, Saro Armenian, DO, MPH, Stephen J. Forman, MD, Smita Bhatia, MD MPH

Blood (2016) 128 (22): 3598.

https://doi.org/10.1182/blood.V128.22.3598.3598

Published: 2016

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Clonal Hematopoiesis Is Associated with Non-Myeloid Subsequent Malignant Neoplasms after Autologous Hematopoietic Cell Transplantation

Clonal Hematopoiesis and Venous Thromboembolism Risk in Lymphoma Patients Surviving Autologous Transplantation

Self-Rated Health Is an Independent Predictor of Subsequent Late Mortality after Blood or Marrow Transplantation (BMT) Among Survivors of Myeloid Malignancies: A BMTSS Report

Social Vulnerability Is an Important Predictor of Cardiovascular Disease Risk after Allogeneic Hematopoietic Cell Transplantation

Individual- and Area-Level Socioeconomic Disadvantage and Risk of Death Due to Chronic Health Conditions Among Autologous Blood or Marrow Transplant (autoBMT) Recipients for Lymphoma: A BMT Survivor Study (BMTSS) Report

Predictors of Risky Health Behaviors Among Blood or Marrow Transplant (BMT) Survivors of Myeloid Malignancies - a BMT Survivor Study (BMTSS)

Self-Rated Health Is an Independent Predictor of Late Mortality after Blood or Marrow Transplantation (BMT) Among Survivors of Plasma Cell Disorders: A BMTSS Report

Predictors of Risky Health Behaviors Among Blood or Marrow Transplant (BMT) Survivors of Lymphoid Malignancies - a BMT Survivor Study (BMTSS)

Self-Rated Health Is an Independent Predictor of Subsequent Late Mortality after Blood or Marrow Transplantation (BMT) Among Survivors of Lymphoid Malignancies: A BMTSS Report

Long-Term Health Outcomes in Older (≥60 Years) Blood or Marrow Transplantation (BMT) Recipients: A Report from the Blood or Marrow Transplant Survivor Study (BMTSS)

Clonal Hematopoiesis Is Associated with Cardiovascular Disease Risk and Worse Survival after Autologous Hematopoietic Cell Transplantation for Lymphoma

Impact of Health Insurance and Access to Autologous Stem Cell Transplantation (ASCT) on Racial Inequity in Overall Survival (OS) Among Patients with Multiple Myeloma (MM)

Clonal Hematopoiesis Is Associated with Severe Cytokine Release Syndrome in Patients Treated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy

Targeted Immunotherapy and Checkpoint Blockade in Children, Adolescents, and Young Adults with Lymphoma: Radical Hodgkin Cohort

Disability Adjusted Life-Years (DALYs) As a Measure of the Changing Lifetime Disease Burden in Long-Term Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT)

Pembrolizumab plus vorinostat induces responses in patients with Hodgkin lymphoma refractory to prior PD-1 blockade

Response-adapted anti-PD-1–based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE

Pembrolizumab Plus Vorinostat Induces Responses in Patients with Hodgkin Lymphoma Who Are Refractory to Prior PD-1 Blockade

Long-Term Follow up of Patients with HIV-Associated Non-Hodgkin Lymphoma (NHL) after Autologous Stem Cell Transplantation (ASCT)

Impact of Self-Reported Pre-Transplant Quality of Life (QOL) on Long-Term Survival after Allogeneic or Autologous Hematopoietic Cell Transplantation (HCT)

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only